Cargando…
558. Evaluating Length of Stay Data for Use in Targeting Prevention of Methicillin-Resistant Staphylococcus aureus (MRSA) Bloodstream Infections
BACKGROUND: Evidence suggests that interventions such as MRSA decolonization are useful in the prevention of MRSA bloodstream infections (BSI) both during hospitalization and post-discharge. However, decolonization may be costly and have diminishing effectiveness when used on all inpatients. Hospita...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6810955/ http://dx.doi.org/10.1093/ofid/ofz360.627 |
_version_ | 1783462361148948480 |
---|---|
author | Gouin, Katryna Hatfield, Kelly M Yi, Sarah H Reddy, Sujan Wolford, Hannah Li, Qunna Edwards, Jonathan R Slayton, Rachel Baggs, James O’Hagan, Justin |
author_facet | Gouin, Katryna Hatfield, Kelly M Yi, Sarah H Reddy, Sujan Wolford, Hannah Li, Qunna Edwards, Jonathan R Slayton, Rachel Baggs, James O’Hagan, Justin |
author_sort | Gouin, Katryna |
collection | PubMed |
description | BACKGROUND: Evidence suggests that interventions such as MRSA decolonization are useful in the prevention of MRSA bloodstream infections (BSI) both during hospitalization and post-discharge. However, decolonization may be costly and have diminishing effectiveness when used on all inpatients. Hospital length of stay (LOS) is a known risk factor for MRSA BSI. To determine whether LOS could be useful in prioritizing patients for intervention, we aimed to evaluate (i) distribution of time from admission to hospital-onset (HO) MRSA BSI, and (ii) frequency and LOS of hospitalizations that preceded community-onset (CO) MRSA BSI. METHODS: MRSA-positive blood cultures among adults admitted to New York hospitals from 2013 to 20s16 were identified in the Centers for Disease Control and Prevention’s (CDC’s) National Healthcare Safety Network (NHSN). We linked these data to admissions in New York’s hospital discharge dataset, the Statewide Planning and Research Cooperative System (SPARCS), where the NHSN blood culture collection date was between a patient’s SPARCS admission and discharge dates and there was an exact match for birth date, gender and facility. Time to MRSA BSI was defined as the number of days from admission (day 1) to collection of a blood culture positive for MRSA. We defined positive blood cultures collected on days 1–3 as CO, and those collected ≥day 4 as HO. RESULTS: We linked 10,425 (79%) MRSA BSIs from NHSN to SPARCS. 78% (8,147) of MRSA BSIs were CO and 22% (2,278) were HO. The median time to HO MRSA BSI was 10 days (IQR 6–21) (Figure 1), in contrast to the median LOS for all hospitalizations of 4 days (IQR 3–7). By definition, 35% of all hospitalizations were never at risk of HO MRSA BSI because their LOS was < 4 days. Among CO MRSA BSI, 48% were discharged from a hospital in the 90 days preceding their BSI (Figure 2). The median LOS of these prior hospitalizations was 8 days (IQR 5–14), and 87% were at least 4 days in length. CONCLUSION: Over half of HO MRSA BSI occur on or after day 10 of hospitalization and a large fraction of CO MRSA BSI had a lengthy hospitalization shortly before their BSI diagnosis. Our results suggest that patients likely to have a long LOS could be evaluated as potential targets for prevention strategies (e.g., decolonization) to reduce both HO and CO MRSA BSI. [Image: see text] [Image: see text] DISCLOSURES: All authors: No reported disclosures. |
format | Online Article Text |
id | pubmed-6810955 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | Oxford University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-68109552019-10-28 558. Evaluating Length of Stay Data for Use in Targeting Prevention of Methicillin-Resistant Staphylococcus aureus (MRSA) Bloodstream Infections Gouin, Katryna Hatfield, Kelly M Yi, Sarah H Reddy, Sujan Wolford, Hannah Li, Qunna Edwards, Jonathan R Slayton, Rachel Baggs, James O’Hagan, Justin Open Forum Infect Dis Abstracts BACKGROUND: Evidence suggests that interventions such as MRSA decolonization are useful in the prevention of MRSA bloodstream infections (BSI) both during hospitalization and post-discharge. However, decolonization may be costly and have diminishing effectiveness when used on all inpatients. Hospital length of stay (LOS) is a known risk factor for MRSA BSI. To determine whether LOS could be useful in prioritizing patients for intervention, we aimed to evaluate (i) distribution of time from admission to hospital-onset (HO) MRSA BSI, and (ii) frequency and LOS of hospitalizations that preceded community-onset (CO) MRSA BSI. METHODS: MRSA-positive blood cultures among adults admitted to New York hospitals from 2013 to 20s16 were identified in the Centers for Disease Control and Prevention’s (CDC’s) National Healthcare Safety Network (NHSN). We linked these data to admissions in New York’s hospital discharge dataset, the Statewide Planning and Research Cooperative System (SPARCS), where the NHSN blood culture collection date was between a patient’s SPARCS admission and discharge dates and there was an exact match for birth date, gender and facility. Time to MRSA BSI was defined as the number of days from admission (day 1) to collection of a blood culture positive for MRSA. We defined positive blood cultures collected on days 1–3 as CO, and those collected ≥day 4 as HO. RESULTS: We linked 10,425 (79%) MRSA BSIs from NHSN to SPARCS. 78% (8,147) of MRSA BSIs were CO and 22% (2,278) were HO. The median time to HO MRSA BSI was 10 days (IQR 6–21) (Figure 1), in contrast to the median LOS for all hospitalizations of 4 days (IQR 3–7). By definition, 35% of all hospitalizations were never at risk of HO MRSA BSI because their LOS was < 4 days. Among CO MRSA BSI, 48% were discharged from a hospital in the 90 days preceding their BSI (Figure 2). The median LOS of these prior hospitalizations was 8 days (IQR 5–14), and 87% were at least 4 days in length. CONCLUSION: Over half of HO MRSA BSI occur on or after day 10 of hospitalization and a large fraction of CO MRSA BSI had a lengthy hospitalization shortly before their BSI diagnosis. Our results suggest that patients likely to have a long LOS could be evaluated as potential targets for prevention strategies (e.g., decolonization) to reduce both HO and CO MRSA BSI. [Image: see text] [Image: see text] DISCLOSURES: All authors: No reported disclosures. Oxford University Press 2019-10-23 /pmc/articles/PMC6810955/ http://dx.doi.org/10.1093/ofid/ofz360.627 Text en © The Author(s) 2019. Published by Oxford University Press on behalf of Infectious Diseases Society of America. http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited. For commercial re-use, please contact journals.permissions@oup.com |
spellingShingle | Abstracts Gouin, Katryna Hatfield, Kelly M Yi, Sarah H Reddy, Sujan Wolford, Hannah Li, Qunna Edwards, Jonathan R Slayton, Rachel Baggs, James O’Hagan, Justin 558. Evaluating Length of Stay Data for Use in Targeting Prevention of Methicillin-Resistant Staphylococcus aureus (MRSA) Bloodstream Infections |
title | 558. Evaluating Length of Stay Data for Use in Targeting Prevention of Methicillin-Resistant Staphylococcus aureus (MRSA) Bloodstream Infections |
title_full | 558. Evaluating Length of Stay Data for Use in Targeting Prevention of Methicillin-Resistant Staphylococcus aureus (MRSA) Bloodstream Infections |
title_fullStr | 558. Evaluating Length of Stay Data for Use in Targeting Prevention of Methicillin-Resistant Staphylococcus aureus (MRSA) Bloodstream Infections |
title_full_unstemmed | 558. Evaluating Length of Stay Data for Use in Targeting Prevention of Methicillin-Resistant Staphylococcus aureus (MRSA) Bloodstream Infections |
title_short | 558. Evaluating Length of Stay Data for Use in Targeting Prevention of Methicillin-Resistant Staphylococcus aureus (MRSA) Bloodstream Infections |
title_sort | 558. evaluating length of stay data for use in targeting prevention of methicillin-resistant staphylococcus aureus (mrsa) bloodstream infections |
topic | Abstracts |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6810955/ http://dx.doi.org/10.1093/ofid/ofz360.627 |
work_keys_str_mv | AT gouinkatryna 558evaluatinglengthofstaydataforuseintargetingpreventionofmethicillinresistantstaphylococcusaureusmrsabloodstreaminfections AT hatfieldkellym 558evaluatinglengthofstaydataforuseintargetingpreventionofmethicillinresistantstaphylococcusaureusmrsabloodstreaminfections AT yisarahh 558evaluatinglengthofstaydataforuseintargetingpreventionofmethicillinresistantstaphylococcusaureusmrsabloodstreaminfections AT reddysujan 558evaluatinglengthofstaydataforuseintargetingpreventionofmethicillinresistantstaphylococcusaureusmrsabloodstreaminfections AT wolfordhannah 558evaluatinglengthofstaydataforuseintargetingpreventionofmethicillinresistantstaphylococcusaureusmrsabloodstreaminfections AT liqunna 558evaluatinglengthofstaydataforuseintargetingpreventionofmethicillinresistantstaphylococcusaureusmrsabloodstreaminfections AT edwardsjonathanr 558evaluatinglengthofstaydataforuseintargetingpreventionofmethicillinresistantstaphylococcusaureusmrsabloodstreaminfections AT slaytonrachel 558evaluatinglengthofstaydataforuseintargetingpreventionofmethicillinresistantstaphylococcusaureusmrsabloodstreaminfections AT baggsjames 558evaluatinglengthofstaydataforuseintargetingpreventionofmethicillinresistantstaphylococcusaureusmrsabloodstreaminfections AT ohaganjustin 558evaluatinglengthofstaydataforuseintargetingpreventionofmethicillinresistantstaphylococcusaureusmrsabloodstreaminfections |